CAS: 2041073-22-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GNF4877 REF: AN-AG01N18OCAS: 2041073-22-5 | 98% | 268.00 €~495.00 € | Mon 06 May 24 |
 | GNF4877 REF: TM-T11447CAS: 2041073-22-5 | 99.11% | 191.00 €~2,756.00 € | Mon 13 May 24 |
 | GNF4877 REF: 3D-RGD07322CAS: 2041073-22-5 | Min. 95% | To inquire | Mon 17 Jun 24 |
Ref: AN-AG01N18O
| 1mg | 268.00 € | |
| 25mg | 323.00 € | |
| 50mg | 495.00 € |
Estimated delivery in United States, on Monday 6 May 2024
GNF4877
CAS:2041073-22-5
GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It …
Formula:
C25H27FN6O4
Purity:
99.11%
Color and Shape:
Solid
Molecular weight:
494.52
Ref: TM-T11447
| 1mg | 191.00 € | |
| 5mg | 537.00 € | |
| 10mg | 848.00 € | |
| 25mg | 1,607.00 € | |
| 50mg | 2,756.00 € |
Estimated delivery in United States, on Monday 13 May 2024
GNF4877
CAS:2041073-22-5
GNF4877 is an oral medication that has been shown to enhance the ability of insulin-producing …
Formula:
C25H27FN6O4
Purity:
Min. 95%
Molecular weight:
494.5 g/mol
Ref: 3D-RGD07322
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
